Tirzepatide Diarrhea: What to Expect on Compounded Tirzepatide
Yes, diarrhea is common on tirzepatide, and for most people it eases with time, whether you inject from a pen or a vial. In weight-loss trials of FDA-approved tirzepatide, 19–23% of people had diarrhea, compared with 8% on placebo, mostly while the dose was being increased (Zepbound prescribing information). Knowing that makes the harder days easier to plan around. Glapp, the GLP-1 tracker, lets you log diarrhea right next to your tirzepatide doses, so you can see which days it tends to hit and watch it settle.
Key numbers
| Number | What it means |
|---|---|
| 19–23% | of people on tirzepatide had diarrhea in weight-loss trials, vs 8% on placebo |
| 9,156 | users currently tracking tirzepatide-related diarrhea in Glapp |
Tirzepatide diarrhea: what the clinical evidence shows
The best evidence on tirzepatide comes from the FDA-approved versions, Zepbound and Mounjaro, which contain the same molecule. In the pooled weight-loss trials behind Zepbound's prescribing information (958 people on placebo, 2,519 on tirzepatide), diarrhea rose with dose:
| Side effect | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Diarrhea | 8% | 19% | 21% | 23% |
Source: Zepbound prescribing information, Table 1.
The prescribing information says most nausea, vomiting and diarrhea happened during dose escalation and decreased over time. It also warns that fluid loss can lead to kidney problems: acute kidney injury was reported in 0.5% of people on tirzepatide vs 0.2% on placebo.
Why does tirzepatide cause diarrhea?
Tirzepatide acts on the gut as well as on appetite, and your digestion needs time to adjust, especially after each dose step. That's why diarrhea clusters around dose increases rather than spreading evenly through treatment.
What you eat on low-appetite days matters: rich, fatty or very sweet foods are common triggers. Your Glapp check-ins show which days diarrhea is worst, which makes it easier to think back to what was different on those days.
Dehydration and electrolytes: why fluids matter most
The biggest risk with diarrhea isn't the diarrhea itself, it's the fluid and electrolytes (sodium and potassium) you lose with it. That's what causes the knock-on dizziness, headaches, cramps and tiredness.
- Signs you're getting dehydrated: thirst, dark urine, peeing less often, dry mouth, dizziness when you stand up.
- Common food triggers: rich, fatty or very sweet foods, and sugar alcohols such as sorbitol in sugar-free sweets and drinks.
Diarrhea that lasts more than a couple of days, comes with blood, fever or severe pain, or leaves you unable to keep fluids down needs a call to your prescriber.
Track your tirzepatide diarrhea with a GLP-1 tracker app
Diarrhea makes it hard to plan a day until you know its pattern. That's what a GLP-1 tracker is for: log it each day next to your tirzepatide doses, and you're in control. You'll know which days after your shot it's most likely, how strong it gets and whether it's easing, and you'll walk into your next appointment with facts instead of guesses.
Why Glapp? It's a top-rated GLP-1 tracker used by 100,000+ people, rated 4.8/5 on Trustpilot and the App Store, and 4.6/5 on Google Play. Glapp grew out of Reddit GLP-1 support groups and is built by people who take GLP-1 medications themselves, which is why it handles the everyday side of compounded tirzepatide that brand-name pen trackers skip:
- Built-in dosage calculator. Glapp shows the units for the dose and concentration you enter. Confirm with your pharmacist.
- Vial and supply tracking. Every dose you log comes off your active vial, so you always know what's left, down to the unit.
It's grounded in published clinical trial data and peer-reviewed research, core tracking is free, and you get custom titration curves plus syncing across iPhone, Android and web. Here's how to use it over your first 30 days.
Glapp does not provide medical advice or treat side effects. It shows your daily check-ins against your estimated medication levels so you have structured data to share with your prescriber.
Day 1: Start tracking your diarrhea
Use Glapp's daily check-in to record diarrhea and rate how severe it feels. Log each dose too.
Daily entries help you see whether diarrhea is getting better, getting worse or staying the same. You'll have a clear record of how you felt, without having to remember every day.
Day 3: Compare symptoms with your estimated tirzepatide level
Glapp estimates your medication level throughout the day using your dose and injection time. Tirzepatide typically reaches its highest blood concentration 8–72 hours after an injection.
Seeing your symptoms alongside this estimate helps you spot when diarrhea appears within your shot cycle. As you log more days, you can look for a repeating pattern and know when to pay closer attention.
The medication level is an estimate, not a blood test, and a matching pattern does not prove what caused your symptoms.
Day 7: See how your diarrhea changes over time
Open the side-effects chart in the Progress tab and choose the period you want to review. Your daily ratings appear on a timeline, making it easier to see whether a difficult day was an isolated episode or part of a longer trend.
Day 14: Look for patterns in your weekly report
Glapp's weekly progress report brings your logged data together, with dedicated sections showing your side effects and how they change.
Does diarrhea tend to return on the same day after your shot? Did it get worse after you started a new vial? Does it coincide with changes in hunger or food noise? Reviewing two weeks of entries can help you spot patterns that are easy to miss day by day, and give you specific questions to discuss with your doctor.
Day 30: Bring a clear record to your doctor
After a month, review the bigger picture: is diarrhea becoming less frequent, staying the same or getting worse? Tirzepatide generally reaches a steady repeating level after about four weeks of weekly injections at the same dose.
Create a doctor's report in Glapp and choose the information to include. Your doctor can review your symptom history alongside your doses and progress, giving you a more focused conversation about your treatment.
Start tracking your tirzepatide diarrhea in Glapp
Diarrhea and dose steps on compounded tirzepatide: units, mg and why measuring matters
Tirzepatide usually starts at 2.5 mg once a week and steps up by 2.5 mg at least four weeks apart, to a maintenance dose between 5 and 15 mg. In the trials, diarrhea rose from 19% at 5 mg to 23% at 15 mg, with most cases in the escalation phase.
Tirzepatide from a vial is drawn up with a U-100 insulin syringe, where 1 unit = 0.01 mL. How many mg that holds depends on your vial's concentration:
mg = units × concentration (mg/mL) ÷ 100
| Dose | Units at 10 mg/mL | Units at 20 mg/mL |
|---|---|---|
| 2.5 mg | 25 | 12.5 |
| 5 mg | 50 | 25 |
| 7.5 mg | 75 | 37.5 |
| 10 mg | 100 | 50 |
| 12.5 mg | 125 | 62.5 |
| 15 mg | 150 | 75 |
Example concentrations only. Concentrations vary between pharmacies, so always use the concentration on your vial and your prescriber's or pharmacist's instructions. Over 100 units is more than a U-100 syringe holds. Ask your pharmacist.
If diarrhea suddenly gets much worse after a new vial, a new pharmacy or a new syringe size, check your concentration and units first, and call your prescriber or pharmacist.
What to bring to your prescriber
A simple log shows your prescriber the pattern at a glance:
| Week | Dose (mg / units) | Diarrhea days | Strongest day after shot | Peak rating | Other side effects logged |
|---|---|---|---|---|---|
| Example 1 | 7.5 mg / 75 units | 4 | Day 1 | High | Nausea |
| Example 2 | 7.5 mg / 75 units | 3 | Day 2 | Med | Nausea |
| Example 3 | 7.5 mg / 75 units | 2 | Day 1 | Med | None |
| Example 4 | 7.5 mg / 75 units | 1 | Day 1 | Low | None |
Questions you could ask. They're conversation starters, not recommendations; your prescriber decides what, if anything, to change.
- "My diarrhea is worst the day after my shot. Is that expected on tirzepatide?"
- "Can you double-check my dose in units against my vial's concentration?"
- "How much fluid should I aim for on days with diarrhea?"
Frequently asked questions
Does compounded tirzepatide cause more diarrhea than Zepbound or Mounjaro?
No trials compare them. When it's the same molecule, the same side effects are expected, but pharmacy-made versions can vary in strength. The FDA has also received reports of adverse events, some serious, that may be related to compounded semaglutide or tirzepatide prescribed in doses beyond the FDA-approved label, with symptoms including nausea, vomiting and diarrhea.
How long does tirzepatide diarrhea last?
For most people, it's a phase. Most diarrhea happened while the dose was being increased and eased over time, so it's usually worst in the first days after starting or a dose step and settles over the following weeks. If it's still going after several weeks on the same dose, talk to your prescriber.
Is tirzepatide diarrhea worse at higher doses?
Slightly. In the trials, diarrhea was reported by 19% at 5 mg, 21% at 10 mg and 23% at 15 mg, compared with 8% on placebo.
How do I track tirzepatide diarrhea?
Log it in Glapp's daily check-in and rate it low, medium or high, with your dose in mg. Glapp shows each rating next to your estimated medication level, so you can see whether it follows your shot.
About the data
Ratings are self-reported and medication levels are estimated from dose and timing, not measured. This page is for information only and is not medical advice; talk to your prescriber about any side effect.
About the author
We're GLP-1 patients and health tech professionals, building Glapp in collaboration with doctors. About us
Sources
- Eli Lilly. Zepbound (tirzepatide) prescribing information: Table 1, warnings (acute kidney injury).
- U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss.